====== Cincreasin 100μM R08 exp473 ====== ==== Mechanism of Action ==== Inhibits budding yeast Mps1 but not human MPS1 (TTK), overrides spindle checkpoint * **Class / Subclass 1:** Signal Transduction / Kinase Inhibitor * **Class / Subclass 2:** Organelle Function / Cytoskeletal Inhibitor * **Class / Subclass 3:** Cell Cycle / Actin Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%6-Bromo-2-benzoxazolinone%% * **Synonyms:** N/A * **CAS #:** 19932-85-5 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/29859|29859]] * **IUPAC:** %%6-bromo-3H-1,3-benzoxazol-2-one%% * **INCHI Name:** InChI=1S/C7H4BrNO2/c8-4-1-2-5-6(3-4)11-7(10)9-5/h1-3H,(H,9,10) * **INCHI Key:** DDNKJFBQMQOIKI-UHFFFAOYSA-N * **Molecular Weight:** 214.02 * **Canonical SMILES:** C1=CC2=C(C=C1Br)OC(=O)N2 * **Isomeric SMILES:** N/A * **Molecular Formula:** C7H4BrNO2 {{:chemogenomics:structures:chem-0282.svg?nolink}} * **Supplier Name:** Combi-Blocks * **Catalog #:** HI-1909 * **Lot #:** B75436 * **LCMS:** Tr 1.16 min, m/z 212- [M-H]- * **Platform ID:** Cincreasin * **Min:** -10.4527; **Max:** 28.7557 {{:chemogenomics:dose_response:dr_519.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |N/A | | IC30 |N/A | | IC40 |N/A | | IC50 |N/A | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 100µM * **Days of incubation**: 8 * **Doublings**: 6.5 * **Numbers of reads**: 20599152 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |1/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Cincreasin_100uM_Round-8_exp473.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp473.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:K:KDSR|KDSR]]|-3.07|<0.01| |[[:human_genes:T:TRIM44|TRIM44]]|-2.62|0.11| |[[:human_genes:C:CHKA|CHKA]]|-2.62|0.08| |[[:human_genes:T:TMED10|TMED10]]|-2.59|0.08| |[[:human_genes:A:AUP1|AUP1]]|-2.47|0.37| |[[:human_genes:C:CYP1A1|CYP1A1]]|-2.43|0.12| |[[:human_genes:D:DYNC1H1|DYNC1H1]]|-2.24|0.83| |[[:human_genes:D:DPAGT1|DPAGT1]]|-2.22|0.45| |[[:human_genes:J:JTB|JTB]]|-2.17|0.37| |[[:human_genes:G:GPR107|GPR107]]|-2.15|0.37| |[[:human_genes:S:SARS|SARS]]|-2.15|0.90| |[[:human_genes:G:GPN1|GPN1]]|-2.15|0.52| |[[:human_genes:S:SLIT1|SLIT1]]|-2.13|0.52| |[[:human_genes:I:IQCD|IQCD]]|-2.00|0.52| |[[:human_genes:Y:YARS|YARS]]|-2.00|0.83| |[[:human_genes:P:P2RY2|P2RY2]]|-2.00|0.52| |[[:human_genes:N:NOSTRIN|NOSTRIN]]|-1.99|0.52| |[[:human_genes:C:CHTOP|CHTOP]]|-1.94|0.69| |[[:human_genes:A:ALG3|ALG3]]|-1.91|0.62| |[[:human_genes:T:TUBA1C|TUBA1C]]|-1.91|0.79| |[[:human_genes:L:LAMTOR4|LAMTOR4]]|-1.91|0.62| |[[:human_genes:T:TBK1|TBK1]]|-1.90|0.62| |[[:human_genes:A:ALG12|ALG12]]|-1.89|0.62| |[[:human_genes:S:SYT10|SYT10]]|-1.89|0.62| |[[:human_genes:P:PPP1R1B|PPP1R1B]]|-1.89|0.62| |[[:human_genes:S:SLC39A10|SLC39A10]]|-1.88|0.63| |[[:human_genes:M:MBTPS2|MBTPS2]]|-1.87|0.63| |[[:human_genes:M:MAGI2|MAGI2]]|-1.85|0.79| |[[:human_genes:F:FETUB|FETUB]]|-1.84|0.69| |[[:human_genes:R:RER1|RER1]]|-1.83|0.69| |[[:human_genes:C:CHAF1A|CHAF1A]]|1.83|0.80| |[[:human_genes:O:OR5R1|OR5R1]]|1.83|0.76| |[[:human_genes:R:RPS13|RPS13]]|1.85|0.80| |[[:human_genes:R:RPS15A|RPS15A]]|1.85|0.83| |[[:human_genes:K:KRTAP4-1|KRTAP4-1]]|1.85|0.76| |[[:human_genes:D:DTX3|DTX3]]|1.86|0.80| |[[:human_genes:C:CNGB3|CNGB3]]|1.90|0.66| |[[:human_genes:P:PSMD7|PSMD7]]|1.91|0.80| |[[:human_genes:R:REV1|REV1]]|1.92|0.65| |[[:human_genes:I:INTS6|INTS6]]|1.93|0.80| |[[:human_genes:E:EPPIN|EPPIN]]|1.94|0.65| |[[:human_genes:M:MST4|MST4]]|1.95|0.65| |[[:human_genes:F:FAM179A|FAM179A]]|1.97|0.76| |[[:human_genes:S:SLC6A17|SLC6A17]]|2.01|0.66| |[[:human_genes:P:PSMC3|PSMC3]]|2.02|0.80| |[[:human_genes:D:DEPDC4|DEPDC4]]|2.04|0.65| |[[:human_genes:S:SDHB|SDHB]]|2.04|0.57| |[[:human_genes:M:MIR205HG|MIR205HG]]|2.08|0.80| |[[:human_genes:C:CDKL1|CDKL1]]|2.10|0.53| |[[:human_genes:K:KIAA0355|KIAA0355]]|2.10|0.65| |[[:human_genes:H:HAT1|HAT1]]|2.11|0.53| |[[:human_genes:K:KRTAP9-9|KRTAP9-9]]|2.15|0.57| |[[:human_genes:E:EXOSC3|EXOSC3]]|2.17|0.57| |[[:human_genes:T:TINF2|TINF2]]|2.18|0.65| |[[:human_genes:T:TMEM174|TMEM174]]|2.22|0.53| |[[:human_genes:F:FRMD1|FRMD1]]|2.24|0.47| |[[:human_genes:R:RPN2|RPN2]]|2.29|0.47| |[[:human_genes:E:EXOSC9|EXOSC9]]|2.29|0.47| |[[:human_genes:A:ATP8B2|ATP8B2]]|2.49|0.47| |[[:human_genes:N:NUP214|NUP214]]|2.53|0.47| ^Screen^Correlation^Plot^ |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|0.06|| {{:chemogenomics:comparison_plots:exp438_vs_exp473.png?nolink |}} ^GO Term^Fold Change^Genes^ |oligosaccharide-lipid intermediate biosynthetic process|85.70|DPAGT1,ALG3,ALG12| |dolichol metabolic process|81.62|DPAGT1,ALG3,ALG12| No GO term hits below threshold. (FDR <0.05)